Vonora fumarate, as a new acid inhibiting agent, has a restorative effect on the stomach, but is not commonly used and preferred for gastric disorders.
1. Vonora fumarate is a kind of potassium ion competitive acid blocker, inhibit the gastric wall cell secretion of gastric acid, so as to have the protection of digestive tract mucosa to reduce the damage, but its adverse reactions are more, the most important treatment disease for reflux esophagitis, not as a common drug for stomach diseases.
2. The adverse reactions of this drug mainly include hepatotoxicity, liver function abnormalities can occur after taking.
3. It should be noted that: the drug can mask the symptoms of malignant tumors; renal insufficiency should be used with caution; the drug reduces the secretion of gastric acid and at the same time can make the stomach alkaline rise, causing gastric discomfort symptoms. It is contraindicated in patients undergoing treatment with atazanavir or rilpivirine.
Drugs should be used under the guidance of a doctor according to the condition, do not blindly use drugs, so as not to cause adverse consequences.